DHA 2016.3 sbir phase II medical r & d contract with guild associates, INC. For proposal no. H2-0354, title: pathogen-specific and serotype-independent antibody reagents for diagnosis of shigella…
Ended Definitive Contract Awarded Last action
- Contract number
- W81XWH18C0091
- Awardee
-
Guild Associates Inc. UEI G1RKNNXESY18
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $999,976
Award facts
- Opportunity
-
- HQ003416R3EDB Solicitation number
- Contract value 100% obligated
- $999,975.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- AN91 R&D- Medical: Other (Basic Research)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 6 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Dublin, OH 43016, USA
- Research
- SBIR Program Phase II Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Original award | $999,976 |
About this award
The U.S. Defense Health Agency (DHA) awarded a $999,975.57 Small Business Innovation Research (SBIR) Phase II contract to Guild Associates, Inc. (doing business as Guild Biosciences) for the development of "Pathogen-Specific and Serotype-Independent Antibody Reagents for Diagnosis of Shigella spp. and Non-Typhoidal Salmonella." This Firm Fixed Price contract was set aside for small businesses and has an ultimate completion date of August 23, 2021. Guild Associates, a manufacturer of industrial products including those for the Department of Defense, has received multiple SBIR grants and contracts from various government agencies to support the development of innovative technologies. This award represents the second phase of a SBIR program to create new diagnostic tools for infectious diseases.
Description
DHA 2016.3 sbir phase II medical r & d contract with guild associates, INC. For proposal no. H2-0354, title: pathogen-specific and serotype-independent antibody reagents for diagnosis of shigella SPP.and non-typhoidal salmonella
Quick answers
Who was awarded contract W81XWH18C0091?
W81XWH18C0091 was awarded to Guild Associates Inc. by Medical Command (Department of the Army) on September 24, 2018.
How much is contract W81XWH18C0091 worth?
The government has obligated $999,976 on W81XWH18C0091.
Which agency awarded contract W81XWH18C0091?
Medical Command (Department of the Army) awarded W81XWH18C0091, with funding from Defense Health Agency (Department of Defense).
Was contract W81XWH18C0091 competed?
The extent of competition for W81XWH18C0091 was full and open competition after exclusion of sources. The government received 6 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award